News

Prof. Dr Christoph Hirneiß presents MINIject at DOC 2021 digital

The DOC (Deutsche Gesellschaft für Ophthalmochirurgie e.V.) are holding their 33rd International Congress of German Ophthalmic Surgeons as a digital event this year from 17 to 19 June 2021. The congress includes an extensive programme with scientific sessions on glaucoma surgery.

MINIject presented at MIGS Symposium 2021

MINIjectTM, iSTAR Medical’s minimally invasive glaucoma surgery (MIGS) device, will be presented in two lectures at the upcoming MIGS Symposium 2021 on Saturday, 17th April from 11:00AM to 2:30PM CET.

MINIject on best-in-class trajectory at Innovation Summit

CEO Michel Vanbrabant presented to an audience of institutional and strategic investors at the Innovation Summit Dublin on 13-15 April.

STAR-II promising results in Ophthalmology Times

The six and 12-month results from the STAR-II trial on MINIjectTM have been reported in the latest issue of Ophthalmology Times.

iSTAR Medical 2021 roadmap at BioCapital Europe

CEO Michel Vanbrabant will present the company’s latest positive developments and an ambitious 2021 roadmap for iSTAR Medical at the Biocapital Europe meeting on 11 March.